Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Corcept Therapeutics Incorporated (CORT) has a Wall Street consensus price target of $68.40, based on estimates from 24 covering analysts. With the stock currently trading at $35.70, this represents a potential upside of +91.6%. The company has a market capitalization of $3.78B.
Analyst price targets range from a low of $30.00 to a high of $100.00, representing a 102% spread in expectations. The median target of $67.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CORT trades at a trailing P/E of 43.5x and forward P/E of 97.6x. Analysts expect EPS to grow -55.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $52.59, with bear and bull scenarios of $18.99 and $214.48 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CORT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for CORT is $68.4, representing 91.6% upside from the current price of $35.7. With 24 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CORT has a consensus rating of "Buy" based on 24 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $68.4 implies 91.6% upside from current levels.
At a forward P/E of 97.6477x, CORT trades at a premium valuation. The consensus price target of $68.4 (91.6% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $100 for CORT, while the most conservative target is $30. The consensus of $68.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $214 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CORT is well covered by analysts, with 24 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 9 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CORT stock forecast based on 24 Wall Street analysts shows a consensus price target of $68.4, with estimates ranging from $30 (bear case) to $100 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $53, with bear/bull scenarios of $19/$214.
Our quantitative valuation model calculates CORT's fair value at $53 (base case), with a bear case of $19 and bull case of $214. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
CORT trades at a forward P/E ratio of 97.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 43.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CORT, with a "Buy" consensus rating and $68.4 price target (91.6% upside). 13 of 24 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CORT analyst price targets range from $30 to $100, a 102% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $68.4 consensus represents the middle ground. Our model's $19-$214 range provides an independent fundamental perspective.